Home
About
Publications Trends
Recent Publications
Expert Search
Archive
antihistamines
Are Antihistamines Used in Cancer Treatment?
While antihistamines are not traditionally used to treat cancer directly, there is growing interest in their potential role in cancer management. Research suggests that they might have a variety of effects on
tumor biology
and the
immune system
.
Frequently asked queries:
What are Antihistamines?
How Do Antihistamines Work?
Are Antihistamines Used in Cancer Treatment?
Can Antihistamines Affect Tumor Growth?
Do Antihistamines Have an Impact on Chemotherapy?
Can Antihistamines Affect the Immune System?
What Are the Risks and Benefits of Using Antihistamines in Cancer Patients?
How Does Genomic Imprinting Relate to Cancer?
How Do Pleiotropic Effects Manifest in Cancer?
Can Pregabalin Be Used in Combination with Other Pain Medications?
What Challenges Exist in Clinical Data Integration?
What Are Some Common Challenges in Communicating with Cancer Patients?
What Are the Common Indoor Air Pollutants?
What is a Hair Transplant?
What Are the Challenges and Criticisms?
Are There Long-Term Gastrointestinal Effects After Cancer Treatment?
What Are the Limitations of ImageJ?
How are Medications Chosen?
What are the Risks of Observation?
How Do Prognostic Biomarkers Impact Treatment Decisions?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe